tiprankstipranks
Blueprint Medicines (BPMC)
NASDAQ:BPMC
US Market

Blueprint Medicines (BPMC) Technical Analysis

Compare
562 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Blueprint Medicines’s (BPMC) Moving Averages Convergence Divergence (MACD) indicator is -1.45, suggesting Blueprint Medicines is a Sell.
Blueprint Medicines’s (BPMC) 20-Day exponential moving average is 90.92, while Blueprint Medicines’s (BPMC) share price is $88.51, making it a Sell.
Blueprint Medicines’s (BPMC) 50-Day exponential moving average is 93.74, while Blueprint Medicines’s (BPMC) share price is $88.51, making it a Sell.

Blueprint Medicines (BPMC) Pivot Points

Apr 01, 2025, 07:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
85.30
86.41
87.57
88.68
89.84
90.95
92.11
Fibonacci
86.41
87.28
87.82
88.68
89.55
90.09
90.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Blueprint Medicines (BPMC) Moving Averages

Apr 01, 2025, 07:44 PM
Period
Simple
Exponential
MA5
90.15Sell
89.62Sell
MA10
90.33Sell
90.07Sell
MA20
89.74Sell
90.92Sell
MA50
98.02Sell
93.74Sell
MA100
96.23Sell
95.02Sell
MA200
96.72Sell
96.86Sell
Blueprint Medicines’s (BPMC) 10-Day exponential moving average is 90.07, while Blueprint Medicines’s (BPMC) share price is $88.51, making it a Sell.
Blueprint Medicines’s (BPMC) 100-Day exponential moving average is 95.02, while Blueprint Medicines’s (BPMC) share price is $88.51, making it a Sell.
Blueprint Medicines’s (BPMC) stock price is $88.51 and Blueprint Medicines’s (BPMC) 50-day simple moving average is 98.02, creating a Sell signal.
Blueprint Medicines’s (BPMC) stock price is $88.51 and Blueprint Medicines’s (BPMC) 100-day simple moving average is 96.23, creating a Sell signal.
Blueprint Medicines’s (BPMC) stock price is $88.51 and Blueprint Medicines’s (BPMC) 200-day simple moving average is 96.72, creating a Sell signal.

Blueprint Medicines (BPMC) Technical Indicators

Apr 01, 2025, 07:44 PM
Name
Value
Implied Action
RSI (14)
43.04
Neutral
STOCH (9,6)
26.37
Neutral
STOCHRSI (14)
35.62
Neutral
MACD (12,26)
-1.45
Sell
ADX (14)
16.59
Buy
Williams %R
-70.38
Buy
CCI (14)
-98.54
Neutral
ATR (14)
3.60
-
Ultimate Oscillator
55.59
Neutral
ROC
0.85
Buy
Blueprint Medicines’s (BPMC) Relative Strength Index (RSI) is 43.04, creating a Neutral signal.
Blueprint Medicines’s (BPMC) Trend Strength Indicator (ADX) is 16.59, creating a Buy signal.
Blueprint Medicines’s (BPMC) Commodity Channel Index (CCI) is -98.54, creating a Neutral signal.
Blueprint Medicines’s (BPMC) Price Rate of Change (ROC) is 0.85, creating a Buy signal.

FAQ

Is BPMC a Buy, Hold, or Sell?
Based on BPMC’s technical indicators, BPMC is a Strong Sell.
    What is BPMC’s RSI (14)?
    BPMC’s RSI (14) is 43.04, which suggests BPMC is a Neutral.
      What is BPMC’s MACD?
      BPMC’s MACD is -1.45, which suggests BPMC is a Sell.
        What is BPMC’s 5-day moving average?
        BPMC’s 5-day moving average is 90.15, which suggests BPMC is a Sell.
          What is BPMC’s 20-day moving average?
          BPMC 20-day moving average is 89.74, which suggests BPMC is a Sell.
            What is BPMC’s 50-day moving average?
            BPMC’s 50-day moving average is 98.02, which suggests BPMC is a Sell.
              What is BPMC’s 200-day moving average?
              BPMC’s 200-day moving average is 96.72, which suggests BPMC is a Sell.
                What is BPMC’s Williams % R (14)?
                BPMC’s Williams % R (14) is -70.38, which suggests BPMC is a Buy.
                  What is BPMC’s CCI (14)?
                  BPMC’s CCI (14) is -98.54, which suggests BPMC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis